CAS: 1454585-06-8
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | N-((4,5-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine REF: IN-DA00ABTACAS: 1454585-06-8 | 98% | 60,00 €~202,00 € | Mar 10 Dic 24 |
 | SR-3029 REF: TM-T3972CAS: 1454585-06-8 | 99.64% | 35,00 €~483,00 € | Vie 13 Dic 24 |
 | SR 3029 REF: 3D-EIC58506CAS: 1454585-06-8 | Min. 95% | A consultar | Vie 17 Ene 25 |
![N-((4,5-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine](https://static.cymitquimica.com/products/IN/thumb/DA00ABTA.jpg)
N-((4,5-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine
CAS:1454585-06-8
Fórmula:
C23H19F3N8O
Pureza:
98%
Forma y color:
Solid
Peso molecular:
480.4452
Ref: IN-DA00ABTA
| 10mg | 60,00 € | ||
| 50mg | 156,00 € | ||
| 100mg | 202,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
SR-3029
CAS:1454585-06-8
SR-3029 is a potent and highly specific CK1δ/CK1ε inhibitor.
Fórmula:
C23H19F3N8O
Pureza:
99.64%
Forma y color:
Solid
Peso molecular:
480.45
Ref: TM-T3972
| 1mg | 35,00 € | ||
| 5mg | 79,00 € | ||
| 10mg | 116,00 € | ||
| 25mg | 241,00 € | ||
| 50mg | 388,00 € | ||
| 1mL*10mM (DMSO) | 84,00 € |
Entrega estimada en Estados Unidos, el Viernes 13 de Diciembre de 2024
SR 3029
CAS:1454585-06-8
SR 3029 is a small-molecule drug that has potent antitumor activity. It inhibits cancer cell …
Fórmula:
C23H19F3N8O
Pureza:
Min. 95%
Peso molecular:
480.45 g/mol
Ref: 3D-EIC58506
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 17 de Enero de 2025
